A proton magnetic resonance spectroscopy study in schizoaffective disorder: Comparison of bipolar disorder and schziophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 37, Issue 1, 2012, Pages 176-181

  Kalayci, Demet ^a   Özdel, Osman ^b   Sözeri Varma, Gülfizar ^b   Kiroǧlu, Yilmaz ^b   Tümkaya, Selim ^b  

^a Antalya Staff Hospital   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Bipolar disorder; Executive function; Magnetic resonance spectroscopy; Schizoaffective disorder; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLYCEROPHOSPHORYLCHOLINE; MOOD STABILIZER; N ACETYLASPARTIC ACID;

ADULT; AGE; ARTICLE; ATTENTION; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG USE; EDUCATIONAL STATUS; EMOTIONAL DISORDER; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; METABOLITE; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOTIC SYMPTOM; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STROOP TEST; SYMPTOM; WISCONSIN CARD SORTING TEST;

ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROTONS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84857785452     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.01.010     Document Type: Article

References (63)

1. Akdemir A, Türkçapar MH, Örsel SD, Demirergi N, Dag I, Özbay MH. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Comprehensive Psychiatry. 2001;42(2):161-165.
2. American Psychiatric Assocation Diagnostic and Statical Manual of Mental Disorders (DSM-IV) 1994, APA Press, Washington DC.
3. Andreasen N.C. Methods for assessing positive and negative symptoms. Modern Problems of Pharmacopsychiatry 1990, 24:73-88.
4. Başoǧlu C., Çetin M., Öner Ö., Ebrinç S., Semiz Ü. Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients. Turkish Journal of Psychiatry 2006, 17:85-92.
5. Béchard-Evans L., Iyer S., Lepage M., Joober R., Malla A. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis. Psychological Medicine 2010, 40:749-759.
6. Bertelsen A., Gottesman I.I. Schizoaffective psychoses: genetical clues to classification. American Journal of Medical Genetics 1995, 60:7-11.
7. Bertolino A., Nawroz S., Mattay V.S., Duyn J.H., Moonen C.T.W., Barnett A.S., et al. A specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. The American Journal of Psychiatry 1996, 153:1554-1563.
8. Bertolino A., Esposito G., Callicott J.H., Mattay V.S., Van Horn J.D., Frank J.A., et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. The American Journal of Psychiatry 2000, 157:26-33.
9. Bowie C.R., Harvey P.D. Cognition in schizophrenia: impairments, determinants, and functional importance. The Psychiatric Clinics of North America 2005, 28:613-633.
10. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. Journal of Affective Disorders 2005, 86:61-67.
11. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biological Psychiatry 1994, 36:792-800.
12. Bustillo J.R., Rowland L.M., Lauriello J., Petropoulos H., Hammond R., Hart B., et al. High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia. The American Journal of Psychiatry 2002, 159:130-133.
13. Cardno A.G., Rijsdijk F.V., West R.M., Gottesman I.I., Craddock Nick, Murray R.M., et al. A Twin Study of Schizoaffective-Mania, Schizoaffective-Depression, and Other Psychotic Syndromes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2012, 159B:172-182.
14. Castillo M., Kwock L., Courvoisie H., Hooper S.R. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. American Journal of Neuroradiology 2000, 21:832-838.
15. Ceylan M.E. Schizoaffective Disorder. Biological Psychiatry-Schizophrenia (Biyolojik Psikiyatri -şizofreni) 2002, vol. 1:793-803. Istanbul, (in turkish). 2 edition.
16. Chang K., Adleman N., Dienes K., Barnea-Goraly N., Reis A., Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry 2003, 53:1059-1065.
17. Chaves O.C., Lombardo L.E., Bearden C.E., Woolsey M.D., Martinez D.M., Barrett J.A., et al. Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study. Bipolar Disorders 2011, 13:118-123.
18. Cheniaux E., Landeira-Fernandez J., Leonardo Lessa Telles L., Lessa J.L., Dias A., Duncan T., et al. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. Journal of Affective Disorders 2008, 106:209-217.
19. Deicken R.F., Eliaz Y., Feiwell R., Schuff N. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Research 2001, 106:35-45.
20. Deicken R.F., Pegues M.P., Anzalone S., Feiwell R., Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. The American Journal of Psychiatry 2003, 160:873-882.
21. Delamillieure P., Fernandez J., Constans J.M., Brazo P., Benali K., Abadie P., et al. Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report. The American Journal of Psychiatry 2000, 157:641-643.
22. Delamillieure P., Constans J.M., Fernandez J., Brazo P., Benali K., Courthéoux P., et al. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophrenia Bulletin 2002, 28:329-339.
23. Elshahawi H.H., Essawi H., Rabie M.A., Mansour M., Beshry Z.A., Mansour A.N. Cognitive functions among euthymic bipolar I patients after a single manic episode versus recurrent episodes. Journal of Affective Disorders 2011, 130:180-191.
24. Erkoç S., Arkonaç O., Atakli C., Özmen E. The reliability and validity of scale for the assesment of the positive symtoms. The Journal of Psychiatry and Neurological Sciences 1991, 4:20-24.
25. Erkoç Ş., Arkonaç O., Atakli C., Özmen E. The reliability and validity of scale for the assesment of the negative symtoms. The Journal of Psychiatry and Neurological Sciences 1991, 4:16-19.
26. Evans J.D., Heaton R.K., Paulsen J.S., McAdams L.A., Heaton S.C., Jeste D.V. Schizoaffective disorder: a form of schizophrenia or affective disorder?. The Journal of Clinical Psychiatry 1999, 60:874-882.
27. Fiszdon J.M., Richardson R., Greig T., Bell M.D. A comparison of basic and social cognition between schizophrenia and schizoaffective disorder. Schizophrenia Research 2007, 91:117-121.
28. Forrester A., Owens D.G., Johnstone E.C. Diagnostic stability in subjects with multiple admissions for psychotic illness. Psychological Medicine 2001, 31:151-158.
29. 1H MRS study. Bipolar Disorders 2007, 9(Suppl. 1):119-127.
30. Galińska B., Szulc A., Tarasów E., Kubas B., Dzienis W., Siergiejczyk L., et al. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia. Medical Science Monitor 2007, 1:11-16.
31. Goldstein G., Shemansky W.J., Allen D.N. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia. Archives of Clinical Neuropsychology 2005, 20:153-159.
32. Gooding D.C., Tallent K.A. Spatial working memory performance in patients with schizoaffective psychosis versus schizophrenia: a tale of two disorders?. Schizophrenia Research 2002, 53:209-218.
33. Hamakawa H., Kato T., Murashita J., Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. European Archives of Psychiatry and Clinical Neuroscience 1998, 248:53-58.
34. Hamakawa H., Kato T., Shioiri T., Inubushi T., Kato N. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes with bipolar disorder. Psychological Medicine 1999, 29:639-644.
35. Hamilton M.A. Rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960, 23:56-62.
36. Harrow M., Grossman L.S., Herbener E.S., Davies E.W. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. The British Journal of Psychiatry 2000, 177:421-426.
37. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curttis C.G. Wisconsin Card Sorting Test manual: revised and expanded 1993, Psycological Assesment Resources, Florida.
38. Jabben N., Arts B., Van Os J., Krabbendam L. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. The Journal of Clinical Psychiatry 2010, 71:764-774.
39. Karadag F., Oral E.T., Aran Yalçin F. Reliability and validity of turkish translation of young mania rating scale. Turkish Journal of Psychiatry 2001, 13:107-114. (in Turkish).
40. Karakaş S. BILNOT Bataryasi El Kitabi: Nöropsikolojik testler için araştirma ve geliştirme çalişmalari 2006, 2. Baski, Eryilmaz Ofset, Ankara, (in Turkish).
41. Kendler K.S., McGuire M., Gruenberg A.M., Walsh D. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study. The American Journal of Psychiatry 1995, 152:755-764.
42. Mahurin R.K., Velligan D.I., Miller A.L. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis. Psychiatry Research 1998, 79:139-149.
43. Malhi G.S., Ivanovski B., Hadzi-Pavlovic D., Mitchell P.B., Vieta E., Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disorders 2007, 9:114-125.
44. Molina V., Sánchez J., Sanz J., Reig S., Benito C., Leal I., et al. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. European Psychiatry 2007, 22:505-512.
45. Monkul E.S., Yildiz A., Soares J.C. Magnetic Resonance Spectroscopy (MRS) applications in bipolar disorder. Turkish Journal of Psychiatry 2004, 15:14-138.
46. Ohrmann P., Kugel H., Bauer J., Siegmund A., Kölkebeck K., Suslow T., et al. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy. Schizophrenia Research 2009, 107:69-75.
47. Ongür D., Prescot A.P., Jensen J.E., Cohen B.M., Renshaw P.F. Creatinen abnormalities in schizophrenia and bipolar disorder. Psychiatry Research 2009, 172:44-48.
48. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports 1962, 10:799-812.
49. Özkürkçügil A., Aydemir Ö., Yildiz M., Esen Danaci A., Köroǧlu E. DSM-IV eksen I bozukluklari için yapilandirilmiş klinik görüşmenin Türkçe'ye uyarlanmasi ve güvenilirlik çalişmasi. ilaç ve Tedavi Dergisi 1999, 12:233-236. (in Turkish).
50. Peralta V., Cuesta M.J. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach. Journal of Affective Disorders 2008, 108:71-86.
51. Perlstein W.M., Carter C.S., Noll D.C., Cohen J.D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. The American Journal of Psychiatry 2001, 158:1105-1113.
52. Sassi R.B., Stanley J.A., Axelson D., Brambilla P., Nicoletti M.A., Keshavan M.S., et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. The American Journal of Psychiatry 2005, 162:2109-2115.
53. Scherk H., Backens M., Schneider-Axmann T., Usher J., Kemer C., Reith W., et al. Cortical neurochemistry in euthymic patients with bipolar I disorder. The World Journal of Biological Psychiatry 2009, 10:285-294.
54. Senaratne R., Milne A.M., MacQueen G.M., Hall G. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder:A proton magnetic resonance spectroscopy study. Psychiatry Research Neuroimaging 2009, 172:205-209.
55. Smith M.J., Barch D.M., Csernansky J.G. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology. The Journal of Clinical Psychiatry 2010, 71:764-774.
56. Stanley J.A., Williamson P.C., Drost D.J., Rylett R.J., Carr T.J., Malla A., et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophrenia Bulletin 1996, 22:597-609.
57. Stroop J.R. The basis of ligons theory American Journal of Psychology 1935, 47:499-504.
58. Szoke A., Meary A., Trandafir A., Bellivier F., Roy I., Schurhoff F., et al. Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder. European Psychiatry 2008, 23:20-25.
59. Torrent C., Martínez-Aran A., Aman B., Daban C., Tabarés-Seisdedos R., González-Pinto A., et al. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatrica Scandinavica 2007, 116:453-460.
60. Weber-Fahr W., Ende G., Braus D.F., Bachert P., Soher B.J., Henn F.A., et al. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. NMR Research in Psychiatry 2002, 16:49-60.
61. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., Ketter T.A. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biological Psychiatry 2000, 47:475-481.
62. Yildiz-Yesiloglu A., Ankerst D.P. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006, 30:969-995.
63. Young R.C., Bigss T., Ziegler V.E., Meyer D.A. A rating scale for mania: Reliability, validity and sensitivity. The British Journal of Psychiatry 1978, 133:429-435.